class name | count |
---|---|
Spermatophyta | 284 |
rosids | 168 |
Embryophyta | 48 |
Magnoliophyta | 7 |
asterids | 6 |
Euphyllophyta | 4 |
eudicotyledons | 3 |
Liliopsida | 1 |
class name | count |
---|---|
Cupressaceae
![]() |
102 |
Araucariaceae
![]() |
58 |
Podocarpaceae
![]() |
52 |
Thymelaeaceae
![]() |
33 |
Zamiaceae
![]() |
27 |
Fabaceae
![]() |
26 |
Ochnaceae
![]() |
24 |
Clusiaceae
![]() |
23 |
Taxaceae
![]() |
20 |
Anacardiaceae
![]() |
18 |
Rhamnaceae
![]() |
12 |
Cycadaceae
![]() |
11 |
Calophyllaceae
![]() |
9 |
Selaginellaceae
![]() |
9 |
Bartramiaceae
![]() |
8 |
Aristolochiaceae
![]() |
6 |
Mniaceae
![]() |
6 |
Hypericaceae
![]() |
5 |
Ginkgoaceae
![]() |
5 |
Cephalotaxaceae
![]() |
5 |
br08003 Category | # of metabolite |
---|---|
Biflavonoids and polyflavonoids | 11 |
KCF-S ID | # of metabolite |
---|---|
No. 34 | 97 |
No. 57 | 70 |
No. 1327 | 7 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
figure |
---|---|---|---|---|---|---|---|
C00042224
![]() |
(S)-4'-Hydroxy-4-methoxydalbergione
|
CHEMBL255296
CHEMBL1374504 |
6 / 4 / 4 | No. 34 |
![]() |
||
C00041635
![]() |
(R)-4-Methoxydalbergione
|
CHEMBL255297
CHEMBL466581 CHEMBL1554531 |
18 / 23 / 57 | No. 34 |
![]() |
||
C00037185
![]() |
(R)-4'-Hydroxy-3,4-dimethoxydalbergione
|
No. 34 |
![]() |
||||
C00001014
![]() |
Isoginkgetin
|
CHEMBL1208903
|
10 / 32 / 61 | No. 34 |
![]() |
||
C00001015
![]() |
Amentoflavone 7'',4'''-dimethyl ether
|
CHEMBL374055
|
2 / 1 / 2 | No. 34 |
![]() |
||
C00001034
![]() |
4',7''-Di-O-methylamentoflavone
/ Amentoflavone 4',7''-dimethyl ether |
CHEMBL208988
|
1 / 0 / 0 | No. 34 |
![]() |
||
C00001044
![]() |
Robustaflavone 7,4'-dimethyl ether
|
CHEMBL453554
|
No. 34 |
![]() |
|||
C00001049
![]() |
Robustaflavone 4',7''-dimethyl ether
|
No. 34 |
![]() |
||||
C00001094
![]() |
5'-Methoxybilobetin
|
No. 34 |
![]() |
||||
C00001098
![]() |
7,7''-Di-O-methylagathisflavone
|
No. 34 |
![]() |
||||
C00035677
![]() |
(rel)-1beta,2alpha-di-(2,4-dihydroxy-6-methoxybenzoyl)-3beta,4alpha-di-(4-methoxyphenyl)-cyclobutane
|
No. 34 |
![]() |
||||
C00034200
![]() |
Mucronulatol-(4->6)-naringenin
|
No. 34 |
![]() |
||||
C00034199
![]() |
Tetrahydrohinokiflavone
/ (-)-Tetrahydrohinokiflavone |
No. 34 |
![]() |
||||
C00020669
![]() |
Afzelone A
|
No. 34 |
![]() |
||||
C00019201
![]() |
Hexaspermone B
|
No. 34 |
![]() |
||||
C00014733
![]() |
Hexaspermone A
|
No. 34 |
![]() |
||||
C00014732
![]() |
Dehydroxyhexaspermone C
|
No. 34 |
![]() |
||||
C00014729
![]() |
Hexaspermone C
|
No. 34 |
![]() |
||||
C00014728
![]() |
Chamaejasmenin C
/ Ruixianglangdusu A |
No. 34 |
![]() |
||||
C00014707
![]() |
Isochamaejasmin
|
CHEMBL467196
CHEMBL452374 |
1 / 0 / 0 | No. 34 |
![]() |
||
C00014700
![]() |
Chamaejasmin
|
CHEMBL467196
CHEMBL452374 |
1 / 0 / 0 | No. 34 |
![]() |
||
C00006431
![]() |
Robustaflavone 7''-methyl ether
|
No. 34 |
![]() |
||||
C00014697
![]() |
Daphnodorin C
|
C055029
|
No. 34 |
![]() |
|||
C00014696
![]() |
Daphnodorin I
|
CHEMBL1362112
|
14 / 20 / 16 | No. 34 |
![]() |
||
C00014695
![]() |
Genkwanol A
/ [2'R-(2'alpha,3'beta,8'alpha,9'alpha)]-3',4'-Dihydro-3',4,5',6-tetrahydroxy-2',8'-bis(4-hydroxyphenyl)-spiro[benzofuran-2(3H),9'(8'H)-[2H]furo[2,3-h][1]benzopyran]-3-one |
CHEMBL1362112
|
C054406
|
14 / 20 / 16 | No. 34 |
![]() |
|
C00014694
![]() |
Daphnodorin G
/ [2S-(2alpha,3beta,7aalpha,13abeta)]-3,4,7a,13a-Tetrahydro-3,5,10,12,13a-pentahydroxy-2,7a-bis(4-hydroxyphenyl)-2H,13H-furo[2,3-b:5,4-h']bis[1]benzopyran-13-one |
No. 34 |
![]() |
||||
C00006446
![]() |
7-O-Methyl-6-C-methylamentoflavone
|
No. 34 |
![]() |
||||
C00006447
![]() |
Ridiculuflavone D
|
No. 34 |
![]() |
||||
C00006448
![]() |
Sciadopitysin
|
CHEMBL208908
|
C086243
|
3 / 3 / 7 | No. 34 |
![]() |
|
C00014693
![]() |
Daphnodorin E
|
CHEMBL2048507
|
6 / 5 / 4 | No. 34 |
![]() |
||
C00006452
![]() |
4',7,7''-Tri-O-methylamentoflavone
/ 7,4',7''-Tri-O-methylamentoflavone |
CHEMBL208578
|
1 / 0 / 0 | No. 34 |
![]() |
||
C00006453
![]() |
Kayaflavone
|
CHEMBL453479
|
1 / 0 / 0 | No. 34 |
![]() |
||
C00006454
![]() |
Abiesin
|
No. 34 |
![]() |
||||
C00006455
![]() |
7,7'',4'''-Tri-O-methylagathisflavone
|
No. 34 |
![]() |
||||
C00006456
![]() |
Cupressuflavone 7,4',7''-trimethyl ether
|
No. 34 |
![]() |
||||
C00014688
![]() |
Daphnogirin B
|
CHEMBL2048507
|
6 / 5 / 4 | No. 34 |
![]() |
||
C00006459
![]() |
Stephaflavone B
/ 5,5'-Dihydroxy-2-(4-hydroxyphenyl)-7,7'-dimethoxy-2'-(4-methoxyphenyl)-[3,6'-bi-4H-1-benzopyran]-4,4'-dione |
No. 34 |
![]() |
||||
C00006460
![]() |
Stephaflavone A
/ 5,5'-Dihydroxy-7,7'-dimethoxy-2,2'-bis(4-methoxyphenyl)-[3,6'-bi-4H-1-benzopyran]-4,4'-dione |
No. 34 |
![]() |
||||
C00006461
![]() |
Agathisflavone tetramethyl ether
|
No. 34 |
![]() |
||||
C00006462
![]() |
Cupressuflavone tetramethyl ether
|
No. 34 |
![]() |
||||
C00006463
![]() |
Amentoflavone 7,4',7'',4'''-tetramethyl ether
|
CHEMBL378516
|
1 / 0 / 0 | No. 34 |
![]() |
||
C00006464
![]() |
Olivieriflavone
|
No. 34 |
![]() |
||||
C00006465
![]() |
Dioonflavone
|
No. 34 |
![]() |
||||
C00014687
![]() |
Daphnogirin A
|
CHEMBL2048507
|
6 / 5 / 4 | No. 34 |
![]() |
||
C00006468
![]() |
Neocryptomerin
|
No. 34 |
![]() |
||||
C00006472
![]() |
Isocryptomerin
|
No. 34 |
![]() |
||||
C00006473
![]() |
Cryptomerin A
|
No. 34 |
![]() |
||||
C00006475
![]() |
Ochnaflavone 4'-methyl ether
|
CHEMBL188147
|
No. 34 |
![]() |
|||
C00006476
![]() |
7''-O-Methylochnaflavone
|
No. 34 |
![]() |
||||
C00006477
![]() |
Chamaecyparin
|
No. 34 |
![]() |
||||
C00006478
![]() |
Cryptomerin B
|
No. 34 |
![]() |
||||
C00014685
![]() |
(2R)-2-Deoxymaesopsin-(2->7)-(2S)-maesopsin
|
No. 34 |
![]() |
||||
C00014684
![]() |
(2S)-2-Deoxymaesopsin-(2->7)-(2S)-maesopsin
|
No. 34 |
![]() |
||||
C00006483
![]() |
Hinokiflavone
|
CHEMBL291426
|
C060299
|
2 / 1 / 2 | No. 34 |
![]() |
|
C00006484
![]() |
Lanaroflavone
|
CHEMBL2172395
|
No. 34 |
![]() |
|||
C00006485
![]() |
Delicaflavone
/ 3-[4-(5,7-Dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
No. 34 |
![]() |
||||
C00006486
![]() |
Loniflavone
|
No. 34 |
![]() |
||||
C00006487
![]() |
Ochnaflavone
|
CHEMBL187504
|
C090940
|
3 / 0 / 0 | No. 34 |
![]() |
|
C00006488
![]() |
Lophirone L
|
No. 34 |
![]() |
||||
C00006489
![]() |
4''',5,5'',7''-Tetrahydroxy-3'',3''',4'-trimethoxy-6-O-alpha,7- beta-flavone-chalcone
|
No. 34 |
![]() |
||||
C00006490
![]() |
4',5,5'',7''-Tetrahydroxy-3',3'',4'''-trimethoxy-6-O-alpha,7-beta-flavone-chalcone
|
No. 34 |
![]() |
||||
C00006491
![]() |
3''',5,5'',7''-Tetrahydroxy-3'',4',4'''-trimethoxy-6-O-alpha,7-beta-flavone-chalcone
|
No. 34 |
![]() |
||||
C00006492
![]() |
4',5,5'',7''-Tetrahydroxy-3',3'',4'''-trimethoxy-6-O-beta,7-alpha-flavone-chalcone
|
No. 34 |
![]() |
||||
C00006493
![]() |
Cissampeloflavone
|
No. 34 |
![]() |
||||
C00006494
![]() |
3''-Desoxydicranolomin
/ 6-[6-(5,7-Dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2,3-dihydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
No. 34 |
![]() |
||||
C00006495
![]() |
Sumaflavone
|
CHEMBL270509
|
1 / 1 / 3 | No. 34 |
![]() |
||
C00006496
![]() |
5'-Hydroxyrobustaflavone
|
No. 34 |
![]() |
||||
C00006497
![]() |
5'-Hydroxyamentoflavone
|
No. 34 |
![]() |
||||
C00006498
![]() |
Moghatin
/ (+)-2-(3,4-Dihydroxyphenyl)-5,5',7,7'-tetrahydroxy-2'-(4-hydroxyphenyl)-[8,8'-bi-4H-1-benzopyran]-4,4'-dione |
No. 34 |
![]() |
||||
C00006499
![]() |
3'''-Hydroxyamentoflavone
|
No. 34 |
![]() |
||||
C00006500
![]() |
Philonotisflavone-4'''-methyl ether
|
No. 34 |
![]() |
||||
C00006501
![]() |
Dicranolomin
|
C421171
|
No. 34 |
![]() |
|||
C00006502
![]() |
Philonotisflavone
|
No. 34 |
![]() |
||||
C00006503
![]() |
5',3'''-Dihydroxyrobustaflavone
|
CHEMBL1990497
|
No. 34 |
![]() |
|||
C00006507
![]() |
5',8''-Biluteolin
|
No. 34 |
![]() |
||||
C00006564
![]() |
Tetrahydroamentoflavone
|
No. 34 |
![]() |
||||
C00014681
![]() |
(2R,3S)-Naringenin-(3alpha->5)-(2S)-maesopsin
|
No. 34 |
![]() |
||||
C00014538
![]() |
3,5,7,4',3'',5'',7''-Heptahydroxy-3'-O-4'''-biflavanone
|
No. 34 |
![]() |
||||
C00014537
![]() |
Hypnogenol A
|
No. 34 |
![]() |
||||
C00014536
![]() |
Hypnogenol B
|
No. 34 |
![]() |
||||
C00014535
![]() |
[5',5']-Bisdihydroquercetin
|
No. 34 |
![]() |
||||
C00014534
![]() |
3,5,7,4',3'',5'',7'',3''',4'''-Nonahydroxy-3',6''-biflavonone
|
No. 34 |
![]() |
||||
C00006598
![]() |
Neorhusflavanone
|
No. 34 |
![]() |
||||
C00006585
![]() |
Rhusflavanone
|
CHEMBL303495
|
No. 34 |
![]() |
|||
C00006566
![]() |
3',3'''-Binaringenin
|
CHEMBL1779459
|
No. 34 |
![]() |
|||
C00006565
![]() |
Biflavanone A
|
No. 34 |
![]() |
||||
C00006534
![]() |
6''-(2-Hydroxy-3-methyl-3-butenyl)amentoflavone
|
No. 34 |
![]() |
||||
C00006535
![]() |
8,'8''-Bibaicalein
|
No. 34 |
![]() |
||||
C00006536
![]() |
Santarubin C
|
No. 34 |
![]() |
||||
C00006537
![]() |
Pentagrametin
|
No. 34 |
![]() |
||||
C00006538
![]() |
Strychnobiflavone
|
No. 34 |
![]() |
||||
C00006541
![]() |
Pyranoamentoflavone 7,4'''-dimethyl ether
|
No. 34 |
![]() |
||||
C00006542
![]() |
Pyranoamentoflavone 7,4'-dimethyl ether
|
No. 34 |
![]() |
||||
C00006543
![]() |
Pyranoamentoflavone 7,4',4'''-Trimethyl ether
|
No. 34 |
![]() |
||||
C00006544
![]() |
Pyranoamentoflavone
|
No. 34 |
![]() |
||||
C00006545
![]() |
Globulixanthone E
|
No. 34 |
![]() |
||||
C00014683
![]() |
(2R)-2-Deoxymaesopsin-(2->7)-(2R)-maesopsin
|
No. 34 |
![]() |
||||
C00006550
![]() |
Tetrahydrorobustaflavone
|
No. 57 |
![]() |
||||
C00006546
![]() |
Kudzuisoflavone A
|
No. 57 |
![]() |
||||
C00006532
![]() |
6''-(3-Methyl-2-butenyl)amentoflavone
|
No. 57 |
![]() |
||||
C00006531
![]() |
Anhydrobartramiaflavone
|
No. 57 |
![]() |
||||
C00006568
![]() |
Jeediflavanone
|
No. 57 |
![]() |
||||
C00006569
![]() |
Semecarpuflavanone
|
No. 57 |
![]() |
||||
C00006570
![]() |
Galluflavanone
|
No. 57 |
![]() |
||||
C00006577
![]() |
Succedaneaflavanone
|
CHEMBL66266
CHEMBL456858 |
No. 57 |
![]() |
|||
C00006530
![]() |
3,8''-Biapigenin
|
CHEMBL515252
|
21 / 16 / 12 | No. 57 |
![]() |
||
C00006529
![]() |
Cupressuflavone
|
CHEMBL1208973
|
6 / 1 / 1 | No. 57 |
![]() |
||
C00008795
![]() |
Biflavanone C
|
No. 57 |
![]() |
||||
C00008797
![]() |
(I-2S,II-2S)-I-7,II-7-Di-O-methyltetrahydroamentoflavone
|
No. 57 |
![]() |
||||
C00000972
![]() |
Ginkgetin
/ 7,4'-Dimethylamentoflavone / Amentoflavone 7'',4'''-dimethyl ether |
CHEMBL377324
|
C077458
|
1 / 0 / 0 | No. 57 |
![]() |
|
C00000976
![]() |
7,7''-Di-O-methylamentoflavone
|
CHEMBL1208793
|
1 / 0 / 0 | No. 57 |
![]() |
||
C00037902
![]() |
(S)-4-Methoxydalbergione
|
CHEMBL255297
CHEMBL466581 CHEMBL1554531 |
18 / 23 / 57 | No. 57 |
![]() |
||
C00000978
![]() |
Putraflavone
/ Podocarpusflavone B |
CHEMBL144630
|
1 / 0 / 0 | No. 57 |
![]() |
||
C00036356
![]() |
(R)-3,4-Dimethoxydalbergione
|
CHEMBL1356393
CHEMBL1591258 |
C026197
|
16 / 37 / 63 | No. 57 |
![]() |
|
C00036031
![]() |
(S)-3'-Hydroxy-4,4'-dimethoxydalbergione
|
CHEMBL1801609
|
No. 57 |
![]() |
|||
C00013286
![]() |
GB1
|
CHEMBL504319
|
C055015
|
No. 57 |
![]() |
||
C00013287
![]() |
GB1a
|
CHEMBL63292
CHEMBL456859 |
No. 57 |
![]() |
|||
C00014530
![]() |
GB-2a
/ (-)-GB-2a |
CHEMBL63792
CHEMBL445452 CHEMBL446790 |
No. 57 |
![]() |
|||
C00006522
![]() |
Agathisflavone
|
CHEMBL65320
|
C079168
|
No. 57 |
![]() |
||
C00006521
![]() |
Taiwaniaflavone
|
CHEMBL272861
|
1 / 1 / 3 | No. 57 |
![]() |
||
C00006520
![]() |
Robustaflavone
|
CHEMBL63677
|
2 / 1 / 3 | No. 57 |
![]() |
||
C00006519
![]() |
Amenthoflavone
|
CHEMBL63354
|
50 / 39 / 29 | No. 57 |
![]() |
||
C00006518
![]() |
Amentoflavone
|
CHEMBL63354
|
C011164
|
50 / 39 / 29 | 5 / 0 | No. 57 |
![]() |
C00014674
![]() |
(2S,3R)-Dihydrogenistein-(2alpha->7)-(2R)-maesopsin
|
No. 57 |
![]() |
||||
C00014675
![]() |
Zeyherin
|
No. 57 |
![]() |
||||
C00014676
![]() |
(2S,3R)-Dihydrogenistein-(2alpha->7)-(2S)-maesopsin
|
No. 57 |
![]() |
||||
C00014677
![]() |
[2R-[2alpha,3beta(S*)]]-3-[2,3-Dihydro-2,4,6-trihydroxy-2-[(4-hydroxyphenyl)methyl]-3-oxo-7-benzofuranyl]-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
|
No. 57 |
![]() |
||||
C00014678
![]() |
[2R-[2alpha,3beta(R*)]]-3-[2,3-Dihydro-2,4,6-trihydroxy-2-[(4-hydroxyphenyl)methyl]-3-oxo-7-benzofuranyl]-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
|
No. 57 |
![]() |
||||
C00014679
![]() |
(2R,3S)-Naringenin-(3alpha->5)-(2R)-maesopsin
|
No. 57 |
![]() |
||||
C00006517
![]() |
Heterobryoflavone
|
No. 57 |
![]() |
||||
C00006516
![]() |
Bryoflavone
|
No. 57 |
![]() |
||||
C00006482
![]() |
Ochnaflavone 7,4'-dimethyl ether
|
No. 57 |
![]() |
||||
C00006481
![]() |
5-Hydroxy-7-methoxyflavone-(4' ->O-> 8'')-5'',7''-dihydroxy-4'''-methoxyflavone
|
No. 57 |
![]() |
||||
C00014686
![]() |
(2S)-2-Deoxymaesopsin-(2->7)-(2R)-maesopsin
|
No. 57 |
![]() |
||||
C00006467
![]() |
5-Hydroxy-7-methoxyflavone-(4' ->O -> 8'')-4''',5'',7''-trihydroxyflavone
|
No. 57 |
![]() |
||||
C00006458
![]() |
Ridiculuflavone C
/ (+)-Ridiculuflavone C |
No. 57 |
![]() |
||||
C00006451
![]() |
Heveaflavone
|
CHEMBL1208904
|
1 / 0 / 0 | No. 57 |
![]() |
||
C00006443
![]() |
7-O-Methylagathisflavone
|
No. 57 |
![]() |
||||
C00006442
![]() |
7''-Methylagathisflavone
|
No. 57 |
![]() |
||||
C00006441
![]() |
7-O-Methylcupressuflavone
|
No. 57 |
![]() |
||||
C00006439
![]() |
4'-O-Methylcupressuflavone
|
No. 57 |
![]() |
||||
C00006429
![]() |
Robustaflavone 4'-methyl ether
|
CHEMBL451902
|
No. 57 |
![]() |
|||
C00014704
![]() |
Neochamaejasmin B
|
CHEMBL467196
CHEMBL452374 |
1 / 0 / 0 | No. 57 |
![]() |
||
C00014706
![]() |
Neochamaejasmin A
|
CHEMBL467196
CHEMBL452374 |
1 / 0 / 0 | No. 57 |
![]() |
||
C00006428
![]() |
Sequoiaflavone
|
CHEMBL255493
|
1 / 0 / 0 | No. 57 |
![]() |
||
C00014708
![]() |
Sikokianin C
|
CHEMBL1172171
CHEMBL1172216 |
No. 57 |
![]() |
|||
C00014709
![]() |
Sikokianin B
|
CHEMBL1172171
CHEMBL1172216 |
No. 57 |
![]() |
|||
C00014710
![]() |
Sikokianin A
/ (+)-Sikokianin A |
CHEMBL1172171
CHEMBL1172216 |
No. 57 |
![]() |
|||
C00014711
![]() |
7-Methylchamaejasmin
|
No. 57 |
![]() |
||||
C00014718
![]() |
Isochamaejasmenin B
|
CHEMBL1545093
|
18 / 28 / 19 | No. 57 |
![]() |
||
C00014719
![]() |
Chamaejasmenin B
|
CHEMBL1545093
|
18 / 28 / 19 | No. 57 |
![]() |
||
C00014720
![]() |
Chamaejasmenin A
|
CHEMBL1545093
|
18 / 28 / 19 | No. 57 |
![]() |
||
C00014726
![]() |
Chamaejasmenin D
/ (+)-Chamaejasmenin D |
No. 57 |
![]() |
||||
C00014727
![]() |
Ruixianglangdusu B
/ (2R,2'R,3S,3'S)-rel-(+)-2,2',3,3'-Tetrahydro-5,5',7-trihydroxy-7'-methoxy-2,2'-bis(4-methoxyphenyl)-[3,3'-bi-4H-1-benzopyran]-4,4'-dione |
No. 57 |
![]() |
||||
C00036030
![]() |
(S)-4,4'-Dimethoxydalbergione
|
CHEMBL1436980
|
14 / 11 / 10 | No. 57 |
![]() |
||
C00006426
![]() |
Sotetsuflavone
|
CHEMBL450522
|
1 / 0 / 0 | No. 57 |
![]() |
||
C00006425
![]() |
Bilobetin
|
CHEMBL378188
|
2 / 1 / 2 | No. 57 |
![]() |
||
C00006424
![]() |
Taiwaniaflavone 4',7''-dimethyl ether
|
No. 57 |
![]() |
||||
C00006423
![]() |
Taiwaniaflavone 7''-O-methyl ether
|
No. 57 |
![]() |
||||
C00006422
![]() |
4',4'''-Di-O-methylcupressuflavone
|
No. 57 |
![]() |
||||
C00030090
![]() |
Afzelone B
|
No. 57 |
![]() |
||||
C00030091
![]() |
7-O-Methyltetrahydroochnaflavone
|
CHEMBL451877
|
No. 57 |
![]() |
|||
C00031675
![]() |
7,7''Di-O-methyl-2,3,2'',3''-tetrahydroochnaflavone
|
CHEMBL448630
|
No. 57 |
![]() |
|||
C00031893
![]() |
7,7''-Di-O-Methyltetrahydrohinokiflavone
|
No. 57 |
![]() |
||||
C00006421
![]() |
7,7''-Di-O-methylcupressuflavone
|
No. 57 |
![]() |
||||
C00006420
![]() |
7,4'''-Di-O-Methylagathisflavone
|
No. 57 |
![]() |
||||
C00006427
![]() |
Podocarpusflavone A
|
CHEMBL220745
|
C094150
|
2 / 1 / 2 | No. 57 |
![]() |
|
C00002549
![]() |
6,6''-Bigenkwanin
/ 5,5'-Dihydroxy-2,2'-bis(4-hydroxyphenyl)-7,7'-dimethoxy-[6,6'-bi-4H-1-benzopyran]-4,4'-dione |
No. 1327 |
![]() |
||||
C00010257
![]() |
GB2
|
CHEMBL510563
CHEMBL508885 |
C055016
|
No. 1327 |
![]() |
||
C00010256
![]() |
Kolaflavanone
|
No. 1327 |
![]() |
||||
C00010255
![]() |
Manniflavanone
/ Garciniflavanone |
No. 1327 |
![]() |
||||
C00010254
![]() |
Gnidia biflavonoid 4a
/ (2S,2'R,3R,3'R)-2,2',3,3'-Tetrahydro-3',5,5',7,7'-pentahydroxy-2-(4-hydroxyphenyl)-2'-(3,4,5-trihydroxyphenyl)-[3,8'-bi-4H-1-benzopyran]-4,4'-dione |
No. 1327 |
![]() |
||||
C00010253
![]() |
Gnidia biflavonoid 4
/ (2R,2'R,3S,3'R)-2,2',3,3'-Tetrahydro-3',5,5',7,7'-pentahydroxy-2-(4-hydroxyphenyl)-2'-(3,4,5-trihydroxyphenyl)-[3,8'-bi-4H-1-benzopyran]-4,4'-dione |
No. 1327 |
![]() |
||||
C00010252
![]() |
7''-O-Methyltetrahydroamentoflavone
|
No. 1327 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P56817 | Beta-secretase 1 | A1A | C00001015 C00001034 C00001044 C00001049 C00001094 C00001098 C00006487 C00006488 C00006489 C00006490 C00006491 C00006492 C00006493 C00006494 C00006495 C00006498 C00006499 C00006500 C00006501 C00042224 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001015 C00002549 C00006427 C00006428 C00006431 C00006494 C00010252 C00010253 C00010254 C00010255 C00013286 C00014530 C00031893 C00042224 | 4 / 3 |
O00255 | Menin | Unclassified protein | C00001015 C00001098 C00002549 C00006427 C00006428 C00006494 C00010252 C00013286 C00014530 C00031893 C00042224 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001015 C00001098 C00002549 C00006427 C00006428 C00006494 C00010252 C00013286 C00014530 C00031893 C00042224 | 1 / 2 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001015 C00001034 C00002549 C00006431 C00010252 C00010254 C00010255 C00013286 C00014530 C00042224 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001015 C00001034 C00006427 C00006428 C00006431 C00013286 C00014530 C00031893 C00042224 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00001015 C00001094 C00006446 C00006484 C00008797 C00030090 C00030091 C00042224 | 1 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001015 C00002549 C00010252 C00010254 C00010255 C00013286 C00014530 C00042224 | 2 / 2 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001015 C00006427 C00006428 C00013286 C00014530 C00031893 C00042224 | 7 / 3 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001015 C00006427 C00006428 C00013286 C00014530 C00031893 C00042224 | 2 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002549 C00006431 C00006494 C00010252 C00010253 C00010254 C00010255 | 0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001015 C00001034 C00006431 C00013286 C00014530 C00042224 | 0 / 0 |
P43235 | Cathepsin K | C1A | C00001015 C00001049 C00006488 C00006490 C00006495 C00042224 | 1 / 2 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002549 C00006431 C00010252 C00010253 C00010254 C00010255 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001015 C00006427 C00006428 C00006431 C00031893 C00042224 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002549 C00006494 C00010252 C00010253 C00010254 C00010255 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00006427 C00006428 C00006431 C00013286 C00014530 C00031893 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002549 C00010252 C00010253 C00010254 C00010255 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001034 C00006427 C00006428 C00006431 C00031893 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001015 C00006427 C00006428 C00031893 C00042224 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001015 C00006427 C00006428 C00031893 C00042224 | 3 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001015 C00002549 C00010252 C00010254 C00042224 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001015 C00006427 C00006428 C00031893 C00042224 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002549 C00010252 C00010253 C00010254 C00010255 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001015 C00006431 C00013286 C00014530 C00042224 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002549 C00010252 C00010254 C00010255 | 0 / 0 |
P05412 | Transcription factor AP-1 | Transcription Factor | C00000972 C00006420 C00006421 C00006422 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00006427 C00006428 C00006431 C00031893 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002549 C00010252 C00010254 C00010255 | 1 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002549 C00006494 C00010252 C00010255 | 3 / 3 |
P11473 | Vitamin D3 receptor | NR1I1 | C00002549 C00010252 C00010254 C00010255 | 2 / 3 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001015 C00001034 C00006431 C00042224 | 1 / 1 |
P54132 | Bloom syndrome protein | Enzyme | C00006427 C00006428 C00006431 C00031893 | 1 / 2 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002549 C00006494 C00010252 C00010255 | 7 / 37 |
P03956 | Interstitial collagenase | M10A | C00008797 C00030090 C00030091 | 0 / 1 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001015 C00006431 C00042224 | 2 / 1 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00001015 C00006431 C00042224 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00006427 C00006428 C00031893 | 1 / 1 |
P17861 | X-box-binding protein 1 | Unclassified protein | C00006427 C00006428 C00031893 | 1 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00006427 C00006428 C00031893 | 1 / 0 |
P45452 | Collagenase 3 | M10A | C00008797 C00030090 C00030091 | 1 / 1 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00006431 C00013286 C00014530 | 0 / 0 |
O15496 | Group 10 secretory phospholipase A2 | Enzyme | C00001015 C00006542 C00042224 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00008797 C00030090 C00030091 | 1 / 0 |
P14555 | Phospholipase A2, membrane associated | Enzyme | C00001015 C00006542 C00042224 | 0 / 0 |
P39900 | Macrophage metalloelastase | M10A | C00008797 C00030090 C00030091 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00008797 C00030090 C00030091 | 2 / 2 |
P37840 | Alpha-synuclein | Unclassified protein | C00006427 C00006428 C00031893 | 4 / 2 |
P47712 | Cytosolic phospholipase A2 | Enzyme | C00001015 C00006542 C00042224 | 0 / 0 |
P19174 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Enzyme | C00001015 C00042224 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001015 C00042224 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001015 C00042224 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00006494 C00010255 | 11 / 10 |
P49763 | Placenta growth factor | Unclassified protein | C00001015 C00042224 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00013286 C00014530 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001015 C00042224 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00013286 C00014530 | 1 / 1 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001015 C00042224 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00006431 C00010255 | 6 / 4 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001015 C00042224 | 1 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001015 C00042224 | 1 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001015 C00042224 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00010254 C00010255 | 2 / 0 |
P55072 | Transitional endoplasmic reticulum ATPase | Unclassified protein | C00001015 C00042224 | 2 / 1 |
P15692 | Vascular endothelial growth factor A | Secreted protein | C00001015 C00042224 | 1 / 2 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001015 C00042224 | 2 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002549 C00010252 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002549 C00010252 | 1 / 4 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001015 C00042224 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001015 C00042224 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001015 C00042224 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001015 C00042224 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001015 C00042224 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001015 C00042224 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001015 C00042224 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001015 C00042224 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001015 C00042224 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001015 C00042224 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001015 C00042224 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001015 C00042224 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001015 C00042224 | 4 / 2 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001015 C00042224 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00010254 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00006431 | 0 / 0 |
P63165 | Small ubiquitin-related modifier 1 | Unclassified protein | C00006431 | 1 / 1 |
P14618 | Pyruvate kinase PKM | Enzyme | C00006431 | 0 / 0 |
P68871 | Hemoglobin subunit beta | Secreted protein | C00006494 | 4 / 4 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00006431 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001015
|
1638 | DCT, TRP-2, TYRP2 | dopachrome tautomerase (EC:5.3.3.12) |
C00001015
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001015
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001015
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00001015
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P47869
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#613954 | Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia; als14 |
P55072
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#210900 | Bloom syndrome; blm |
P54132
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P18054
P84022 Q14191 |
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#133239 | Esophageal cancer |
P04637
P18054 |
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#167320 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1; ibmpfd1 |
P55072
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#612371 | Major affective disorder 7; mafd7 |
P17861
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#603933 | Microvascular complications of diabetes, susceptibility to, 1; mvcd1 |
P15692
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#613705 | Orofacial cleft 10; ofc10 |
P63165
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#265800 | Pycnodysostosis |
P43235
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#603903 | Sickle cell anemia |
P68871
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00028 | Choriocarcinoma |
P03956
(related)
P04637 (related) P08253 (related) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
P15692 (related) |
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) P68871 (marker) |
H00022 | Bladder cancer |
P04637
(related)
P68871 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
P15692 (marker) |
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
P55072 (related) |
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00273 | Pycnodysostosis |
P43235
(related)
|
H00425 | Lysosomal cysteine protease deficiencies |
P43235
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00516 | Isolated orofacial clefts |
P63165
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|